$PFSA Cashflow Statement | Understand Stock

$PFSA

$0.77 -$0.01 (1.78%) Close

$PFSA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 8 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Interest income on cash and marketable securities held in Trust Account
Offering costs allocated to warrant liabilities
Change in fair value of convertible note
Noncash interest expense
Noncash loss on change in fair value of convertible notes
Noncash issuance of inducement shares and in connection with the merger
Noncash issuance of warrants to financial advisor
Noncash issuance of warrants associated for ELOC Warrants
Loss on disposition of property and equipment, net
Stock-based compensation expenses
Gain on change in fair value of warrant liabilities
Changes in fair value of convertible promissory note
Loss on change in fair value of digital assets
Noncash merger transaction costs

Changes in assets and liabilities:
Other receivables
Prepaid expenses and other current assets
Accrued offering costs and expenses
Accounts payable and accrued expenses
Prepaid income taxes
Income tax payable
Deferred tax liability
Due to related party
Other non-current assets
Accounts payable
Accrued expenses and other current liabilities
Net cash used in operating activities
Cash flows from investing activities
Investment of cash in Trust Account
Overpayment of amount due to related party
Payment of extension fee into Trust Account
Cash withdrawn from Trust Account in connection with redemption
Reimbursement of franchise and income taxes from Trust Account
Reimbursement by related party–
Reimbursement by related party
Purchase of digital assets
Purchase of property, plant and equipment
Net cash used in investing activities

Cash flows from financing activities
Proceeds from initial public offering, net of underwriters’ discount
Proceeds from private placement
Payment of promissory notes to related party
Proceeds from issuance of notes
Proceeds from ELOC
Proceeds from issuance of loans payable
Proceeds from issuance of convertible loan
Advance from Profusa
Redemption of common stock
Net cash received from the reverse recapitalization
Repayment of convertible notes, senior notes, promissory notes and other
Payment of deferred offering costs
Net cash provided by financing activities
Net change in cash

Net increase in cash
Cash at the beginning of the period
Cash at the end of the period
Supplemental disclosures of non-cash investing and financing information:
Assumption of net liabilities of Northview
Increase in unpaid deferred offering costs
Conversion of preferred stock into common stock
Conversion of debt to equity
Financing of D&O insurance premium
Supplemental disclosure of cash flow information:
Initial classification of warrant liabilities
Income taxes paid, inclusive of interest and penalties
Accretion of common stock to redemption value
Deferred offering costs paid through issuance of founder shares
Deferred offering costs paid through issuance of promissory note
Deferred offering costs included in accrued offering costs and expenses
Excise tax payable attributable to redemption of common stock
Reclassification of common stock subject to redemption to common stock to be redeemed
Cash paid for interest
Cash paid for taxes

Comments